NovaVive Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
NovaVive General Information
Description
Developer of a veterinary immunotherapeutic platform designed to address unmet veterinary medical needs. The company's platform engages in offering mycobacterium cell wall fractions technology with regulator-approved products, demonstrating the capability of reducing the reliance on antibiotics in the treatment of bacterial diseases of cattle and horses, enabling customers to treat the viral equine respiratory disease of livestock and companion animal diseases effectively.
Contact Information
Website
www.novavive.caCorporate Office
- 15 Dairy Avenue
- Napanee, Ontario K7R 1M4
- Canada
Corporate Office
- 15 Dairy Avenue
- Napanee, Ontario K7R 1M4
- Canada
NovaVive Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Angel (individual) | 19-Dec-2018 | Cancelled | Generating Revenue | |||
| 2. Angel (individual) | 20-Jun-2016 | Cancelled | Generating Revenue | |||
| 1. Angel (individual) | Completed | Generating Revenue |
NovaVive Signals
NovaVive FAQs
-
When was NovaVive founded?
NovaVive was founded in 2014.
-
Where is NovaVive headquartered?
NovaVive is headquartered in Napanee, Canada.
-
What is the size of NovaVive?
NovaVive has 10 total employees.
-
What industry is NovaVive in?
NovaVive’s primary industry is Other Commercial Products.
-
Is NovaVive a private or public company?
NovaVive is a Private company.
-
What is NovaVive’s current revenue?
The current revenue for NovaVive is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process